Hansa Biopharma Deploys Cradle’s AI Platform Across Discovery Pipeline

Hansa Biopharma has partnered with Cradle to deploy its AI-driven protein design platform across Hansa's drug discovery pipeline, aiming to accelerate development of novel immunomodulatory therapies for autoimmune diseases. Hansa selected Cradle for its end-to-end discovery support, multi-parameter optimization, and active learning capabilities.